| [1] | Wu S., Wang Y., Liu J., et al. (2026). Stroke in China: advances in prevention and management on the path to a healthy China. Lancet Neurol. 25:379−395. DOI:10.1016/S1474-4422(26)00009-8 |
| [2] | Jia J., Zhai Y., Wang C., et al. (2026). China Stroke Statistics 2023: a report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, National Collaborating Centre for Neurological Disorders Prevention, the Chinese Stroke Association and Institute for Global Neuroscience and Stroke Collaborations. Stroke Vasc. Neurol. Published online July 31:2026. DOI:10.1136/svn-2026-005565 |
| [3] | Huo X., Ma G., Tong X., et al. (2023). Trial of endovascular therapy for acute ischemic stroke with large infarct. N. Engl. J. Med. 388:1272−1283. DOI:10.1056/NEJMoa2213379 |
| [4] | Gao Y., Chen W., Pan Y., et al. (2023). Dual antiplatelet treatment up to 72 hours after ischemic stroke. N. Engl. J. Med. 389:2413−2424. DOI:10.1056/NEJMoa2309137 |
| [5] | Ma L., Hu X., Song L., et al. (2023). The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet 402:27−40. DOI:10.1016/S0140-6736(23)00806-1 |
| Wang G., Wu C. and Ji X. (2026). From acute rescue to lifelong brain health: China’s transformation in stroke care and science. The Innovation Neurology 1:100002. https://doi.org/10.59717/j.xinn-tine.2026.100002 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
China’s evolving stroke discipline: from capacity building to a learning health system